Latest News
After a huge rally earlier this month, Poet has been getting hit with big pullbacks.
Via The Motley Fool · May 19, 2026
Harmony Biosciences develops therapies for rare neurological disorders, with WAKIX addressing excessive sleepiness in narcolepsy patients.
Via The Motley Fool · May 19, 2026
This company has transformed itself into an AI advertising stock, but after a massive run, the real question is whether the platform can still justify the premium.
Via The Motley Fool · May 19, 2026
Via Talk Markets · May 19, 2026
Red Robin (RRGB) Q1 2026 Earnings Transcript
Via The Motley Fool · May 19, 2026
Honda's EV strategy failed, so the car company is refocusing on its core strengths.
Via The Motley Fool · May 19, 2026
Today, May 19, 2026, long-term Treasury yields rose again, rattling U.S. stocks ahead of a pivotal Nvidia earnings test.
Via The Motley Fool · May 19, 2026
Fresh capital for AI photonic interconnects collides with mounting dilution, today, May 19, 2026.
Via The Motley Fool · May 19, 2026
The "Magnificent Seven" are looking less magnificent in 2026. This low-cost index fund could be a better buy.
Via The Motley Fool · May 19, 2026
Cisco and Lumentum delivered better-than-expected earnings results this quarter, and their valuations reflect Wall Street’s optimism.
Via The Motley Fool · May 19, 2026
Grupo Financiero Galicia (NASDAQ:GGAL) management said profitability weakened sharply in the first quarter of 2026, as higher loan-loss provisions, limited loan demand and inflation accounting effects weighed on results, even as margins and efficiency showed sequential improvement.
Pablo Firvida, h
Via MarketBeat · May 19, 2026
Adagene (NASDAQ:ADAG) Chief Strategy Officer Mickael Chane-Du outlined the company’s clinical strategy for its lead antibody program, ADG126, during a discussion with Stifel senior biotech analyst Stephen Willey, emphasizing the company’s focus on improving the therapeutic index of CTLA-4 inhibition
Via MarketBeat · May 19, 2026
Quantum computers might be further away from commercialization than initially thought.
Via The Motley Fool · May 19, 2026
Enbridge (TSX:ENB) and another dividend titan worth buying and holding.
Via The Motley Fool · May 19, 2026
The age you file for Social Security will be one of the most important retirement-related decisions you’ll make.
Via The Motley Fool · May 19, 2026
Canaan (CAN) Q1 2026 Earnings Transcript
Via The Motley Fool · May 19, 2026
These stocks are backed by strong fundamentals, resilient operating models, and sustained long-term demand for their products and solutions.
Via The Motley Fool · May 19, 2026
Nauticus Robotics (KITT) Q1 2026 Earnings Transcript
Via The Motley Fool · May 19, 2026
Gemini Space (GEMI) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 19, 2026
do you have $10,000 that you are looking to deploy tax-free in your TFSA? These four quality stocks could deliver great long-term returns.
Via The Motley Fool · May 19, 2026
Homebuilding company Toll Brothers (NYSE:TOL) announced better-than-expected revenue in Q1 CY2026, but sales fell by 7.6% year on year to $2.53 billion. Its ...
Via StockStory · May 19, 2026
The semiconductor giant is poised for years of business growth ahead.
Via The Motley Fool · May 19, 2026
Silicon Motion Technology has almost tripled year-to-date as more investors recognize the opportunity.
Via The Motley Fool · May 19, 2026
Via Benzinga · May 19, 2026
All three of these Canadian ETFs boast low fees and decent diversification.
Via The Motley Fool · May 19, 2026